MedPath

Assessing the Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses

Not Applicable
Completed
Conditions
Astigmatism
Refractive Errors
Presbyopia
Registration Number
NCT05886907
Lead Sponsor
Alcon Research
Brief Summary

The purpose of this clinical trial is to assess on-eye performance and overall fit of an investigational multifocal toric contact lens to aid in confirmation of the study lens design.

Detailed Description

Subjects will attend 3 study visits with a planned individual duration of participation of up to 10 days.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
18
Inclusion Criteria
  • Requires ADD (additional power for near vision);
  • Currently wears multifocal soft contact lenses in both eyes during the past 3 months;
  • Manifest cylinder power between -0.75 diopter (D) and -1.00 D;
  • Best Corrected Visual Acuity (BCVA) of logMAR 0.10 (Snellen 20/25) or better in each eye.
  • Other protocol-specified inclusion criteria may apply.

Key

Exclusion Criteria
  • Any anterior segment infection, inflammation, or abnormality or disease (including systemic) that contraindicates contact lens wear, as determined by the Investigator;
  • Any use of systemic or ocular medications for which contact lens wear could be contraindicated, as determined by the Investigator;
  • Current or history of pathologically dry eye in either eye that, in the opinion of the Investigator, would preclude contact lens wear;
  • Monovision contact lens wear.
  • Other protocol-specified exclusion criteria may apply.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Mean Distance Visual Acuity (VA) With Study LensesDay 2, each wear period. A wear period was approximately 2 days.

Visual Acuity (VA) was assessed binocularly (both eyes together) with study lenses in place at a distance of 4 meters using letter charts. VA was recorded in logarithm minimum angle of resolution (logMAR), where 0.0 logMAR equates to 20/20 Snellen (normal distance eyesight). A lower number indicates better visual acuity. No hypothesis testing is pre-specified for this endpoint.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Johns Creek Research Clinic

🇺🇸

Johns Creek, Georgia, United States

Johns Creek Research Clinic
🇺🇸Johns Creek, Georgia, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.